Description
Additional file 4: Supplementary Fig. 4. Progression-free survival of patients with ETS ≥ 20% vs. ETS
| Dati resi disponibili | 2022 |
|---|---|
| Editore | figshare |
Additional file 4 of Early tumor shrinkage and response assessment according to mRECIST predict overall survival in hepatocellular carcinoma patients under sorafenib
- Osman Öcal (Creator)
- Regina Schinner (Creator)
- Kerstin Schütte (Creator)
- Enrico N. De Toni (Creator)
- Christian Loewe (Creator)
- Otto van Delden (Creator)
- Vincent Vandecaveye (Creator)
- Bernhard Gebauer (Creator)
- Christoph J Zech (Creator)
- Christian Sengel (Creator)
- Irene Bargellini (Creator)
- Antonio Gasbarrini (Creator)
- Bruno Sangro (Creator)
- Maciej Pech (Creator)
- Peter Malfertheiner (Creator)
- Jens Ricke (Creator)
- Max Seidensticker (Creator)
Dataset